Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

KEXXTONE DIN 02451999

Status: Marketed
Holder: ELANCO CANADA LIMITED
Molecule: MONENSIN (MONENSIN SODIUM)

Health Canada record

Active ingredient(s)MONENSIN (MONENSIN SODIUM) 32.4 G
Dosage formCapsule
RouteOral
ScheduleNON-PRESCRIPTION DRUGS
ClassVeterinary
ATC
Original market date05-Jan-2017
Current status date19-Jun-2018
SourceHealth Canada DPD

Establishment licence of the holder

Elanco Canada Limited — licence 102236, currently licensed, last inspection rating C (2022-08-03).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing MONENSIN (MONENSIN SODIUM)

DINProductCompanyFormStrengthStatus
02231172COBAN PREMIXELANCO CANADA LIMITEDDrug PremixMONENSIN (MONENSIN SODIUM) 200 GMarketed
02243232MONENSIN PREMIXBIO AGRI MIX LPDrug PremixMONENSIN (MONENSIN SODIUM) 200 GMarketed
02516772MONOVETHUVEPHARMA EOODDrug PremixMONENSIN (MONENSIN SODIUM) 200 GMarketed
02231173RUMENSIN PREMIXELANCO CANADA LIMITEDDrug PremixMONENSIN (MONENSIN SODIUM) 200 GMarketed
02082128RUMENSIN CRCELANCO CANADA LIMITEDCapsule (Extended-Release)MONENSIN (MONENSIN SODIUM) 32 GCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
200772017-11-21New Drug Submission (NDS)MERGER - BUYOUT
177692016-02-12New Drug Submission (NDS)
Request a quote for KEXXTONE

How to read a Canadian DIN record